Reimbursement of Anti-Obesity Medicines Wegovy and Mounjaro Starts Monday in France
5 Articles
5 Articles
Management of 65% of medicines should be combined with a lower calorie diet and increased physical activity.
The anti-obesity treatments Wegovy and Mounjaro enter the reimbursement of the Health Insurance as of this Monday. Reserved for the most severe forms of obesity, this treatment is accompanied by strict criteria that will initially limit the number of beneficiaries.
lejsl.com
bienpublic.comThese medicines are covered at 65% by the Health Insurance as of Monday, but many people should continue to buy them without care.
The anti-obesity treatments Wegovy and Mounjaro will now be reimbursed to 65% by sickness insurance for certain patients suffering from severe obesity. An expected advance, but accompanied by strict eligibility criteria and numerous prescription constraints, limiting the number of beneficiaries in the immediate future. A new step will open up in the management of obesity in France. Starting this Monday, the medicines Wegovy and Mounjaro, which h…
Coverage Details
Bias Distribution
- 100% of the sources lean Left
Factuality
To view factuality data please Upgrade to Premium
